A Prospective Pharmacogenomic Study of Crohn's Disease Patients during Routine Therapy with Anti-TNF-α Drug Adalimumab: Contribution ofATG5,NFKB1,andCRPGenes to Pharmacodynamic Variability

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
A Prospective Pharmacogenomic Study of Crohn's Disease Patients during Routine Therapy with Anti-TNF-α Drug Adalimumab: Contribution ofATG5,NFKB1,andCRPGenes to Pharmacodynamic Variability
Authors
Keywords
-
Journal
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
Volume 20, Issue 5, Pages 296-309
Publisher
Mary Ann Liebert Inc
Online
2016-04-21
DOI
10.1089/omi.2016.0005

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.